Feature Channels: Vaccines

• share
• favorite_border

• share
• favorite_border

Anthony S. Fauci, MD, will discuss COVID-19 – including the latest on potential vaccines – in a free Zoom presentation at noon Nov. 18 during Medical Center Hour at the University of Virginia School of Medicine.

• share
• favorite_border

• share
• favorite_border

Major measles outbreaks will likely occur during 2021 as an unexpected consequence of the COVID-19 pandemic, according to a new academic article.

• share
• favorite_border

A vaccine created to prevent the recurrence of the deadly skin cancer melanoma is about twice as effective when patients also receive two components that boost the number and effectiveness of immune system cells called dendritic cells, according to phase 2 clinical trial results published in Nature Cancer in November.

• share
• favorite_border

• share
• favorite_border

Younger parents were much less likely than older parents to say they planned to vaccinate their children and themselves against COVID-19, according to a research letter published online in medRxiv by authors at the Vanderbilt University School of Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago and Northwestern University Feinberg School of Medicine.

• share
• favorite_border

In March 2020, as the pandemic was sweeping the globe and establishing roots in Australia, the Complex Systems Centre at the University of Sydney modelled how varying rates of social distancing could affect the spread of the COVID-19 pandemic across a very diverse Australian population.

• share
• favorite_border

The COVID-19 Research Symposium, hosted by the Mount Sinai Clinical Intelligence Center (MSCIC), is a one-day comprehensive review of advances in research by the Mount Sinai Health System to better understand and treat the coronavirus known as COVID-19.

• share
• favorite_border

Half of vaccines are wasted annually because they aren’t kept cold. Michigan Tech and UMass Amherst chemical engineers have discovered a way to stabilize viruses in vaccines with proteins instead of temperature.

• share
• favorite_border

• share
• favorite_border

A potential breakthrough in the early detection of the neck, head and anal cancers linked to human papilloma viruses (HPV) has emerged. It is based on a highly specific diagnostic test that appears to indicate cancer, and predict its course, from just a pinprick of blood.

• share
• favorite_border

Published: November 10, 2020 | 3:47 pm | SHARE: There may be good news on the horizon regarding a COVID-19 vaccine.Pfizer and partner BioNTech reported that their trial vaccine appears to have a 90 percent efficacy rate, meaning that test subjects who received a vaccine experienced 90 percent fewer cases of symptomatic COVID-19 than those who received a placebo.

• share
• favorite_border

The first COVID-19 vaccines could be authorised as early as the start of 2021.

• share
• favorite_border

• share
• favorite_border

Newborns and young infants are particularly susceptible to the flu and are six times more likely to die from the infection than older children. Currently there is no flu vaccine available for babies less than 6 months old.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

ACTIV-2 will evaluate the safety and efficacy of investigational treatments for adults who have COVID-19, but do not require hospitalization. ACTIV-2 is a randomized, blinded, controlled study that tests a variety of new agents against placebo. This approach allows promising investigational agents to be added and removed over the course of the study.

• share
• favorite_border

In a new Science Advances study, Shresta and her colleagues at LJI report that the immune system's T cells have the power to prevent Zika infection in mice. This finding suggests that effective Zika vaccines need to activate T cells to work alongside antibodies.